The first nalmefene hydrochloride (HCl) auto-injector (Zurnai) brings a new tool to the fight against the opioid overdose epidemic but is not without controversy. As reported earlier this month, the US Food and Drug Administration (FDA) approved Purdue Pharma’s abbreviated new drug application for a prefilled…
